TrialBreast cancer research and treatment2019

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.

Matteo Lambertini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.